ALTEOGEN Inc. (196170.KQ)

KRW 286500.0

(-3.54%)

Total Debt Summary of ALTEOGEN Inc.

ALTEOGEN Inc.'s latest annual total debt in 2023 was 83.76 Billion KRW , down -2.03% from previous year.
ALTEOGEN Inc.'s latest quarterly total debt in 2024 Q2 was 100.38 Billion KRW , up 13.19% from previous quarter.
ALTEOGEN Inc. reported annual total debt of 85.5 Billion KRW in 2022, down -25.4% from previous year.
ALTEOGEN Inc. reported annual total debt of 114.61 Billion KRW in 2021, up 27.48% from previous year.
ALTEOGEN Inc. reported quarterly total debt of 88.68 Billion KRW for 2024 Q1, up 5.87% from previous quarter.
ALTEOGEN Inc. reported quarterly total debt of 83.76 Billion KRW for 2023 FY, down -2.03% from previous quarter.

Annual Total Debt Chart of ALTEOGEN Inc. (2023 - 2012)

Historical Annual Total Debt of ALTEOGEN Inc. (2023 - 2012)

Year	Total Debt	Total Debt Growth
2023	83.76 Billion KRW	-2.03%
2022	85.5 Billion KRW	-25.4%
2021	114.61 Billion KRW	27.48%
2020	89.9 Billion KRW	1437.57%
2019	5.84 Billion KRW	224.84%
2018	1.8 Billion KRW	0.0%
2017	- KRW	0.0%
2016	- KRW	0.0%
2015	- KRW	0.0%
2014	- KRW	-100.0%
2013	1.33 Billion KRW	0.0%
2012	- KRW	0.0%

Year	Total Debt	Total Debt Growth
2024 Q2	100.38 Billion KRW	13.19%
2024 Q1	88.68 Billion KRW	5.87%
2023 FY	83.76 Billion KRW	-2.03%
2023 Q4	83.76 Billion KRW	0.38%
2023 Q1	87.31 Billion KRW	2.12%
2023 Q3	83.45 Billion KRW	0.04%
2023 Q2	83.41 Billion KRW	-4.47%
2022 Q4	85.5 Billion KRW	-0.6%
2022 Q2	85.17 Billion KRW	-0.38%
2022 FY	85.5 Billion KRW	-25.4%
2022 Q1	85.5 Billion KRW	-25.4%
2022 Q3	86.01 Billion KRW	0.99%
2021 Q4	114.61 Billion KRW	69.39%
2021 FY	114.61 Billion KRW	27.48%
2021 Q2	68.23 Billion KRW	377.25%
2021 Q3	67.66 Billion KRW	-0.84%
2021 Q1	14.29 Billion KRW	274.05%
2020 Q4	3.82 Billion KRW	-9.23%
2020 Q3	4.21 Billion KRW	1.23%
2020 Q1	4.14 Billion KRW	-0.27%
2020 Q2	4.15 Billion KRW	0.45%
2020 FY	89.9 Billion KRW	1437.57%
2019 Q2	3.61 Billion KRW	100.69%
2019 Q3	4.09 Billion KRW	13.24%
2019 FY	5.84 Billion KRW	224.84%
2019 Q1	1.8 Billion KRW	0.0%
2019 Q4	4.15 Billion KRW	1.49%
2018 Q1	246.76 Million KRW	0.0%
2018 Q4	1.8 Billion KRW	20.0%
2018 FY	1.8 Billion KRW	0.0%
2018 Q2	- KRW	-100.0%
2018 Q3	1.5 Billion KRW	0.0%
2017 Q1	- KRW	0.0%
2017 FY	- KRW	0.0%
2017 Q3	150 Million KRW	0.0%
2017 Q2	- KRW	0.0%
2017 Q4	- KRW	-100.0%
2016 Q2	190.98 Million KRW	0.0%
2016 Q3	- KRW	-100.0%
2016 Q4	- KRW	0.0%
2016 FY	- KRW	0.0%
2016 Q1	- KRW	0.0%
2015 FY	- KRW	0.0%
2015 Q2	- KRW	0.0%
2015 Q1	- KRW	0.0%
2015 Q3	- KRW	0.0%
2015 Q4	- KRW	0.0%
2014 Q4	- KRW	0.0%
2014 FY	- KRW	-100.0%
2014 Q2	1.2 Billion KRW	0.0%
2014 Q1	- KRW	-100.0%
2013 Q3	1.33 Billion KRW	0.0%
2013 Q1	- KRW	0.0%
2013 Q4	1.33 Billion KRW	0.0%
2013 FY	1.33 Billion KRW	0.0%
2012 FY	- KRW	0.0%

Peer Total Debt Comparison of ALTEOGEN Inc.

Name	Total Debt	Total Debt Difference
HLB Co., Ltd.	62.7 Billion KRW	-33.592%
iNtRON Biotechnology, Inc.	402.9 Million KRW	-20691.052%
BINEX Co., Ltd.	53.5 Billion KRW	-56.557%
Bioneer Corporation	44.63 Billion KRW	-87.655%
Anterogen.Co.,Ltd.	9.74 Billion KRW	-760.017%
MEDIPOST Co., Ltd.	52.33 Billion KRW	-60.055%
CrystalGenomics, Inc.	32 Billion USD	-161.753%
Helixmith Co., Ltd	20.22 Billion KRW	-314.13%
Chabiotech Co.,Ltd.	449.63 Billion KRW	81.37%
Medy-Tox Inc.	82.83 Billion KRW	-1.134%
Peptron, Inc.	9.13 Billion KRW	-817.215%
Amicogen, Inc.	149.59 Billion KRW	44.003%
Genexine, Inc.	67.42 Billion KRW	-24.236%
HLB Therapeutics Co.,Ltd.	10.02 Billion KRW	-735.823%
LegoChem Biosciences, Inc.	12.64 Billion KRW	-562.524%
PharmaResearch Co., Ltd.	34.3 Billion KRW	-144.177%
SillaJen, Inc.	9.69 Billion KRW	-763.9%
JETEMA, Co., Ltd.	130.49 Billion KRW	35.808%
OliX Pharmaceuticals,Inc	39.35 Billion KRW	-112.842%
Genomictree Inc.	1.83 Billion KRW	-4465.927%
MedPacto, Inc.	8.6 Billion KRW	-873.594%
D&D Pharmatech	8.13 Billion KRW	-929.826%
EASY BIO,Inc.	82.27 Billion KRW	-1.812%
GI Innovation, Inc.	3.72 Billion KRW	-2151.355%